Taro adds new member to board
HAWTHORNE, N.Y. — Taro Pharmaceutical Industries recently appointed a new member to its board, following the resignation of Hasmukh Shah.
Shah, who cited personal reasons for leaving the drug maker's board, was replaced by Dov Pekelman, who currently serves as chairman of both Atera Networks and Gilon Investments. Pekelman also served as senior consultant for Teva Pharmaceutical Industries from 1985 to 2008.
Pekelman will serve until Taro's next annual general meeting of shareholders.